Micha Zimra-Ben
Jerusalem, JM 91120, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models.
Journal: Pharmacological reports : PR
Published: February 11, 2026
CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
Journal: International archives of allergy and immunology
Published: December 30, 2025
2B4: A potential target in Staphylococcus aureus associated allergic inflammation.
Journal: Clinical and experimental immunology
Published: January 29, 2023
The regulatory role of eosinophils in viral, bacterial, and fungal infections.
Journal: Clinical and experimental immunology
Published: November 03, 2021
Dexamethasone and CD300a activation display additive inhibitory effect on human and murine mast cell functions.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 29, 2021
Perturbations in the Replication Program Contribute to Genomic Instability in Cancer.
Journal: International journal of molecular sciences
Published: April 06, 2017
Papain Activates Human Mast Cells to Release Proinflammatory Mediators via its Enzymatic Activity.
Journal: The Journal of investigative dermatology
Published: October 18, 2015
Siglec-7 is an inhibitory receptor on human mast cells and basophils.
Journal: The Journal of allergy and clinical immunology
Published: June 02, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026